Targeting the Gut Microbiome for Inflammation and Pain Management in Orthopedic Conditions.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 35700403.
- Also identified by DOI 10.3928/01477447-20220608-07.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The human gut microbiome can be altered with probiotics, prebiotics, synbiotics, and anti-inflammatory foods and spices as part of an evidence-based strategy that targets inflammation and pain in common orthopedic conditions. Implementing these strategies avoids adverse effects associated with nonsteroidal anti-inflammatory drugs and minimizes the potential for opioid use. This review focuses exclusively on human trials studying the effects of gut microbiome alterations to address pain and inflammatory markers in common orthopedic conditions: osteoarthritis, rheumatoid arthritis, fractures/osteoporosis, and bone pain associated with chemotherapy. Individualized supplementation strategies can be further explored with the information in this review. [<i>Orthopedics</i>. 2022;45(5):e226-e234.].
Medical subject headings
- Gastrointestinal Microbiome